These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 26138778)

  • 1. Increased γ-H2AX and Rad51 DNA Repair Biomarker Expression in Human Cell Lines Resistant to the Chemotherapeutic Agents Nitrogen Mustard and Cisplatin.
    Adam-Zahir S; Plowman PN; Bourton EC; Sharif F; Parris CN
    Chemotherapy; 2014; 60(5-6):310-20. PubMed ID: 26138778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for different mechanisms of 'unhooking' for melphalan and cisplatin-induced DNA interstrand cross-links in vitro and in clinical acquired resistant tumour samples.
    Spanswick VJ; Lowe HL; Newton C; Bingham JP; Bagnobianchi A; Kiakos K; Craddock C; Ledermann JA; Hochhauser D; Hartley JA
    BMC Cancer; 2012 Sep; 12():436. PubMed ID: 23020514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Xrcc3 induces cisplatin resistance by stimulation of Rad51-related recombinational repair, S-phase checkpoint activation, and reduced apoptosis.
    Xu ZY; Loignon M; Han FY; Panasci L; Aloyz R
    J Pharmacol Exp Ther; 2005 Aug; 314(2):495-505. PubMed ID: 15843498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone H2AX phosphorylation as a molecular pharmacological marker for DNA interstrand crosslink cancer chemotherapy.
    Clingen PH; Wu JY; Miller J; Mistry N; Chin F; Wynne P; Prise KM; Hartley JA
    Biochem Pharmacol; 2008 Jul; 76(1):19-27. PubMed ID: 18508035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential contributory roles of nucleotide excision and homologous recombination repair for enhancing cisplatin sensitivity in human ovarian cancer cells.
    Wang QE; Milum K; Han C; Huang YW; Wani G; Thomale J; Wani AA
    Mol Cancer; 2011 Mar; 10():24. PubMed ID: 21385444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro studies on the mechanisms of oxaliplatin resistance.
    Hector S; Bolanowska-Higdon W; Zdanowicz J; Hitt S; Pendyala L
    Cancer Chemother Pharmacol; 2001 Nov; 48(5):398-406. PubMed ID: 11761458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics of H2AX phosphorylation after exposure to cisplatin.
    Olive PL; Banáth JP
    Cytometry B Clin Cytom; 2009 Mar; 76(2):79-90. PubMed ID: 18727058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin overcomes resistance to cisplatin in triple-negative breast cancer (TNBC) cells by targeting RAD51.
    Lee JO; Kang MJ; Byun WS; Kim SA; Seo IH; Han JA; Moon JW; Kim JH; Kim SJ; Lee EJ; In Park S; Park SH; Kim HS
    Breast Cancer Res; 2019 Oct; 21(1):115. PubMed ID: 31640742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro evidence for homologous recombinational repair in resistance to melphalan.
    Wang ZM; Chen ZP; Xu ZY; Christodoulopoulos G; Bello V; Mohr G; Aloyz R; Panasci LC
    J Natl Cancer Inst; 2001 Oct; 93(19):1473-8. PubMed ID: 11584063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular resistance to chloroethylnitrosoureas, nitrogen mustard, and cis-diamminedichloroplatinum(II) in human glial-derived cell lines.
    Aida T; Bodell WJ
    Cancer Res; 1987 Mar; 47(5):1361-6. PubMed ID: 3469016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of ERβ induces resistance to cisplatin by enhancing Rad51-mediated DNA repair in human medulloblastoma cell lines.
    Wilk A; Waligorska A; Waligorski P; Ochoa A; Reiss K
    PLoS One; 2012; 7(3):e33867. PubMed ID: 22439007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acquired resistance to combination treatment with temozolomide and ABT-888 is mediated by both base excision repair and homologous recombination DNA repair pathways.
    Liu X; Han EK; Anderson M; Shi Y; Semizarov D; Wang G; McGonigal T; Roberts L; Lasko L; Palma J; Zhu GD; Penning T; Rosenberg S; Giranda VL; Luo Y; Leverson J; Johnson EF; Shoemaker AR
    Mol Cancer Res; 2009 Oct; 7(10):1686-92. PubMed ID: 19825992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resveratrol decreases Rad51 expression and sensitizes cisplatin‑resistant MCF‑7 breast cancer cells.
    Leon-Galicia I; Diaz-Chavez J; Albino-Sanchez ME; Garcia-Villa E; Bermudez-Cruz R; Garcia-Mena J; Herrera LA; García-Carrancá A; Gariglio P
    Oncol Rep; 2018 Jun; 39(6):3025-3033. PubMed ID: 29620223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential regulation of DNA repair protein Rad51 in human tumour cell lines exposed to doxorubicin.
    Koehn H; Magan N; Isaacs RJ; Stowell KM
    Anticancer Drugs; 2007 Apr; 18(4):419-25. PubMed ID: 17351394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased gene specific repair of cisplatin induced interstrand crosslinks in cisplatin resistant cell lines, and studies on carrier ligand specificity.
    Petersen LN; Mamenta EL; Stevnsner T; Chaney SG; Bohr VA
    Carcinogenesis; 1996 Dec; 17(12):2597-602. PubMed ID: 9006094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of homologous recombination in human cells by targeting RAD51 recombinase.
    Huang F; Mazina OM; Zentner IJ; Cocklin S; Mazin AV
    J Med Chem; 2012 Apr; 55(7):3011-20. PubMed ID: 22380680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of platinum drug resistance by the histone deacetylase inhibitor belinostat.
    To KK; Tong WS; Fu LW
    Lung Cancer; 2017 Jan; 103():58-65. PubMed ID: 28024697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of ERCC1 and Rad51 expression through ERK1/2 inactivation is essential in emodin-mediated cytotoxicity in human non-small cell lung cancer cells.
    Ko JC; Su YJ; Lin ST; Jhan JY; Ciou SC; Cheng CM; Lin YW
    Biochem Pharmacol; 2010 Feb; 79(4):655-64. PubMed ID: 19799875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Let-7e sensitizes epithelial ovarian cancer to cisplatin through repressing DNA double strand break repair.
    Xiao M; Cai J; Cai L; Jia J; Xie L; Zhu Y; Huang B; Jin D; Wang Z
    J Ovarian Res; 2017 Apr; 10(1):24. PubMed ID: 28376831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melanoma cells replicate through chemotherapy by reducing levels of key homologous recombination protein RAD51 and increasing expression of translesion synthesis DNA polymerase ζ.
    Song L; McNeil EM; Ritchie AM; Astell KR; Gourley C; Melton DW
    BMC Cancer; 2017 Dec; 17(1):864. PubMed ID: 29254481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.